Sign in
4/A

Changes in Ownership

Outlook Therapeutics, Inc. Filed Acc 0001209191-18-064381

Options or other derivatives

  • Director acquired 1,468 shares (other)

From the SEC's structured data for this filing

Trades in this filing

BioLexis Pte Ltd. · Director

Table II: Derivative

1 line
Date Transaction Shares Underlying Owned after D/I
2018-09-30 Other acquisition : show line 1 in the form Series A-1 Convertible Preferred Stock +1,468 221,937 60,203 D
Loading xslF345X03/doc4a.xml…